Monitoring of the oncological process for lung cancer in Spain: an expert consensus report

• Javier de Castro ^[1] ; Patricia Alonso-Fernández ^[2] ; José Javier Castrodeza ^[3] ; Ángel Gayete ^[4] ; Florentino Hernando ^[2] ; José Martínez-Olmos ^[5] ; Bartomeu Massuti ^[6] ; Luis Paz-Ares ^[8] ; Antoni Sisó-Almirall ^[9] ; David Vicente ^[7] ; Laureano Molins ^[10]
  1. [1] Hospital Universitario La Paz

     Hospital Universitario La Paz

     Madrid, España

     
  2. [2] Hospital Clínico San Carlos de Madrid

     Hospital Clínico San Carlos de Madrid

     Madrid, España

     
  3. [3] Hospital Universitario de Valladolid

     Hospital Universitario de Valladolid

     Valladolid, España

     
  4. [4] Hospital del Mar

     Hospital del Mar

     Barcelona, España

     
  5. [5] Escuela Andaluza de Salud Pública

     Escuela Andaluza de Salud Pública

     Granada, España

     
  6. [6] Hospital General Universitario de Alicante

     Hospital General Universitario de Alicante

     Alicante, España

     
  7. [7] Hospital Universitario Virgen Macarena

     Hospital Universitario Virgen Macarena

     Sevilla, España

     
  8. [8] Department of Medical Oncology, Hospital Universitario 12 Octubre, Madrid, Spain
  9. [9] Consorci d’Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain
  10. [10] Department of Thoracic Surgery, Hospital Clínic, Barcelona University, Barcelona, Spain

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 27, Nº. 10, 2025, págs. 3867-3876
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Introduction Continuous monitoring of the oncological process is essential for identifying inefficiencies and areas of improvement, enabling better resource allocation in the care of lung cancer patients.

    Objective The objective is to define key indicators and identify critical variables for monitoring lung cancer care, aiming to improve early detection, reduce delays in diagnosis and treatment, and enhance biomarker research, ensuring timely and effective treatments for all patients.

    Methods A multidisciplinary expert group conducted a consensus process based on a review of national guidelines and initiatives related to lung cancer care. The experts defined relevant indicators and identified variables for monitoring overall care, addressing delays, and improving biomarker research. The feasibility of incorporating these indicators into existing information systems was also assessed.

    Results The proposed indicators provide a structured approach for assessing lung cancer care and outcomes. Their inclusion in healthcare information systems would improve the monitoring and evaluation of care quality and patient outcomes.

    Additionally, these indicators would also promote interoperability and continuous patient care across different centers and regions, allowing informed decision-making in the improvement of healthcare processes by those responsible for healthcare management.

    Conclusions The adoption of standardized indicators for lung cancer care monitoring can drive continuous improvement in healthcare processes. Implementing these indicators in information systems will enable better resource allocation, timely and effective treatment, and enhanced coordination among healthcare providers, ultimately improving patient outcomes.